Produkty 56985-40-1

CAS 56985-40-1 występuje w naszej ofercie pod nazwami: U 46619, U 46619, U-46619, 9,11-DIDEOXY-11A,9A-EPOXYMETHANO- PROSTA, U-46619, 99.79%. Oferty producentów: GLPBio, TRC, TargetMol, Biosynth, Sigma-Aldrich. Dostępne opakowania: 1mg, 100mg, 5mg, 10mg, 2mg, 25mg, 1 mg (28.5 mM * 100 μL in Methyl acetate), 10 mg (28.5 mM * 1 mL in Methyl acetate).

U 46619
GLPBio
  • opakowanie: 1mg, 10mg, 5mg
  • Warianty: 3
od 1046,37
Zobacz produkt
U 46619
TRC, Biosynth
  • opakowanie: 100mg, 2mg, 1mg, 5mg
  • Warianty: 6
Zobacz produkt
U-46619
TargetMol, Chemat
  • opakowanie: 1mg, 5mg, 10mg
  • Warianty: 4
od 1727,19
Zobacz produkt
9,11-DIDEOXY-11A,9A-EPOXYMETHANO- PROSTA
Sigma-Aldrich
  • opakowanie: 1MG, 5MG
  • Warianty: 2
od 1530,00
Zobacz produkt
U-46619, 99.79%
MedChemExpress
  • opakowanie: 1 mg (28.5 mM * 100 μL in Methyl acetate), 10 mg (28.5 mM * 1 mL in Methyl acetate), 5 mg (28.5 mM * 500 μL in Methyl acetate)
  • Warianty: 3
od 1703,60
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(Z)-7-[(1R,4S,5S,6R)-6-[(E,3S)-3-hydroxyoct-1-enyl]-2-oxabicyclo[2.2.1]heptan-5-yl]hept-5-enoic acid (CAS 56985-40-1) to związek chemiczny o wzorze sumarycznym C21H34O4 i masie molowej 350.5 g/mol. Nazwa systematyczna IUPAC: (Z)-7-[(1R,4S,5S,6R)-6-[(E,3S)-3-hydroxyoct-1-enyl]-2-oxabicyclo[2.2.1]heptan-5-yl]hept-5-enoic acid. InChIKey: LQANGKSBLPMBTJ-BRSNVKEHSA-N.

Dane identyfikacyjne
Wzór sumarycznyC21H34O4
Masa molowa350.5 g/mol
Nazwa IUPAC(Z)-7-[(1R,4S,5S,6R)-6-[(E,3S)-3-hydroxyoct-1-enyl]-2-oxabicyclo[2.2.1]heptan-5-yl]hept-5-enoic acid
InChIKeyLQANGKSBLPMBTJ-BRSNVKEHSA-N
SMILESCCCCC[C@@H](/C=C/[C@H]1[C@H]2C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)CO2)O

Dane obliczone przez PubChem (NCBI)

Synonimy: 9,11-Methanoepoxy PGH2, 11alpha,9alpha-epoxymethano-PGH2, 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid, 9alpha-PGM, PUC, 9alpha,11alpha-Methanoepoxy-PGF2alpha, Opera_ID_380, BSPBio_001534, orb1706500, 9a,11a-Methanoepoxy-15-hydroxyprosta-5,13-dienoic acid
Powiązane formy tego związku
(E)-7-[(5S,6R)-6-[(E,3S)-3-hydroxyoct-1-enyl]-2-oxabicyclo[2.2.1]heptan-5-yl]hept-5-enoic acid C21H34O4
Izomery (ten sam wzór sumaryczny)
1-[(3R,5R,8S,9S,10S,11S,13S,14S,17S)-3,11-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-hydroxyethanone C21H34O4
1-[(3R,5S,8S,9S,10S,11S,13S,14S,17S)-3,11-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-hydroxyethanone C21H34O4
(3R,5R,8S,9S,10S,13S,14S,17R)-3,17-dihydroxy-17-[(1S)-1-hydroxyethyl]-10,13-dimethyl-2,3,4,5,6,7,8,9,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-11-one C21H34O4
1-[(3R,5R,8R,9S,10S,13S,14S,17R)-3,17-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2-hydroxyethanone C21H34O4
methyl (8E,11E,14E,17E)-5,6-dihydroxyicosa-8,11,14,17-tetraenoate C21H34O4
(3R,5R,8S,9S,10S,13S,14S,17S)-17-[(1R)-1,2-dihydroxyethyl]-3-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-11-one C21H34O4
(5E)-5-[(3aS,4R,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydro-1H-pentalen-2-ylidene]pentanoic acid C21H34O4
1-[(3R,5S,8S,9S,10S,11S,13S,14S,17S)-3,11,17-trihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone C21H34O4
1-[(3S,5S,8S,9S,10S,11S,13S,14S,17S)-3,11-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-hydroxyethanone C21H34O4
(3R,5R,8S,9S,10S,13S,14S,17S)-17-[(1S)-1,2-dihydroxyethyl]-3-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-11-one C21H34O4
(3S,5R,8S,9S,10S,13S,14R,17R)-3,17-dihydroxy-17-[(1R)-1-hydroxyethyl]-10,13-dimethyl-2,3,4,5,6,7,8,9,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-11-one C21H34O4